Why Some Transferred Fat Survives a BBL and Some Does Not

When surgeons describe a Brazilian Butt Lift, they often talk about shape, projection, and contour. What gets less airtime is the underlying biological gamble: every BBL is a fat grafting procedure, and grafted fat must survive a hostile transition from one part of the body to another. Published estimates of long-term fat retention typically fall between 50 and 80 percent, which is a wide range. Understanding why helps patients set realistic expectations and ask better questions in consultation.

Fat is living tissue, not filler. Adipocytes, the cells that store fat, are metabolically active and fragile. When fat is suctioned from the abdomen, flanks, or thighs, it is disconnected from its blood supply. From that moment, a clock starts. The cells must survive without oxygen until the body builds new circulation around them at the recipient site. Cells that never reconnect die, are broken down by the immune system, and are reabsorbed. This is why buttock volume at three months looks smaller than volume at one week. Early fullness includes swelling and fat that is already dying.

The three-phase survival process. Grafted fat survives through a sequence that transplant biology describes in three stages. First comes plasmatic imbibition, roughly the first 48 hours, when fat cells absorb nutrients passively from surrounding tissue fluid, like a sponge soaking up broth. Second is inosculation, when tiny existing blood vessels in the graft begin connecting to vessels in the recipient tissue, usually within the first several days. Third is revascularization, when the body grows entirely new capillaries into the graft over the following weeks. Fat that sits too far from a capillary during phase one simply starves before phases two and three can rescue it.

Why injection technique matters more than volume. The starvation problem explains a core principle of modern fat grafting: small amounts, distributed widely. Research on graft geometry suggests fat deposited in thin strands or small parcels survives at much higher rates than fat injected in large boluses, because oxygen can only diffuse a short distance into tissue, on the order of a millimeter or two. A large pooled deposit of fat has a center that no capillary can reach in time. That center dies, and dead fat can liquefy into oil cysts, calcify into firm nodules, or trigger fat necrosis, which can feel like hard lumps under the skin. Surgeons who fan the cannula through many tissue planes and deposit fat in fine ribbons are not being fussy. They are working with diffusion physics.

The subcutaneous-only rule is about safety, but it also affects retention. Following multi-society safety advisories, the standard of care is to inject fat only into the subcutaneous layer, above the gluteal muscle, never into or below it. The reason is safety: intramuscular injection risks fat entering large deep veins and causing a pulmonary fat embolism, the most serious BBL complication. But the subcutaneous plane is also a finite space. It accepts a limited volume before tissue pressure rises, and elevated pressure within the graft site compresses the fragile new capillaries the graft depends on. Overfilling a fixed space can paradoxically reduce the amount of fat that survives. This is one mechanistic reason many surgeons now favor moderate volumes per session, sometimes staging a second procedure, rather than maximizing volume in one sitting.

Patient factors are not trivial. Nicotine in any form constricts blood vessels and impairs the capillary growth that revascularization depends on, which is why most surgeons require weeks of complete nicotine cessation before and after surgery. Significant weight fluctuation after surgery also changes results: transferred fat cells behave like the cells at their donor site, so they shrink with weight loss and enlarge with weight gain. Pressure is another variable. Sitting directly on freshly grafted fat in the early weeks can compress the graft during its most vulnerable revascularization window, which is the rationale behind off-loading cushions and modified sitting protocols, though the strength of evidence behind exact timelines is limited and protocols vary.

What patients should take from this. First, expect volume loss. A result that settles at 60 to 70 percent of the initial transferred volume is not a failure, it is biology. Second, ask a prospective surgeon how they distribute fat, what plane they inject into, and how they decide total volume. Answers grounded in tissue capacity and safety are a good sign. Third, protect the graft during the first six to eight weeks: no nicotine, stable weight, and follow the sitting guidance you are given. The surgeon controls harvesting, processing, and placement. The patient controls much of the environment those cells must survive in afterward. Retention is a partnership, and understanding the mechanism is the first step in holding up your half.

Related reading: How Much Transferred Fat Actually Survives a BBL, and Why.